PeptidePopularWeight lossHeart

Tirzepatide

Also called Mounjaro, Zepbound

A once-a-week GLP-1 and GIP medicine for weight loss and type 2 diabetes (Mounjaro, Zepbound).

Usual amount
2.5–15 mg
commonly reported
How it’s taken
Injection under the skin
Half-life
about 5 days
half of it gone after
Good after mixing
28 days
in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.

What it is

Tirzepatide acts on two gut hormone receptors, GLP-1 and GIP. It curbs appetite and improves blood sugar. In the SURMOUNT-1 trial, people on the highest dose lost about 21% of their body weight over 72 weeks.

How it’s used

  • Injected under the skin once a week.
  • Start at 2.5 mg and go up by 2.5 mg after at least 4 weeks on each dose.

Typical amounts

  • Labeled doses: 2.5, 5, 7.5, 10, 12.5 and 15 mg a week.
  • 2.5 mg is a starting dose to get used to it, not a treatment dose.

Good to know

  • Prescription medicine. Nausea, diarrhea and constipation are common early on and after dose increases.
  • It can make birth control pills less reliable for 4 weeks after starting and after each increase.
  • Not for people with a personal or family history of medullary thyroid cancer or MEN 2.

Educational information, not medical advice. Check anything you take with a doctor or pharmacist.